Literature DB >> 457282

Two-dimensional gel electrophoretic comparison of proteins from virulent and avirulent strains of Mycoplasma pneumoniae.

E J Hansen, R M Wilson, J B Baseman.   

Abstract

The protein composition of the virulent M129 strain of Mycoplasma pneumoniae was compared to that of its homologous avirulent strain by the use of standard one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Forty-nine individual M. pneumoniae cell proteins were resolved by this method, and the virulent strain was shown to possess a single high-molecular-weight protein not present in avirulent cells. Variability in the resolution of this particular protein in one-dimensional gels prompted the application of two-dimensional gel electrophoresis to the analysis of M. pneumoniae cell proteins. The sequential use of isoelectric focusing in the first dimension and sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the second dimension permitted the resolution of a least 142 individual M. pneumoniae cell proteins. Application of nonequilibrium pH gradient electrophoresis in the first dimension achieved the resolution of at least 20 additional basic proteins. Three proteins which are synthesized only by cells of the virulent strain, and not by the homologous avirulent strain, were identified by these two-dimensional gel electrophoresis techniques.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457282      PMCID: PMC414325          DOI: 10.1128/iai.24.2.468-475.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Determination of the specific radioactivity of proteins separated by two-dimensional gel electrophoresis.

Authors:  M Buisson; A M Reboud; J P Reboud
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

3.  High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

Authors:  P Z O'Farrell; H M Goodman; P H O'Farrell
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

4.  Chemical measurement of steady-state levels of ten aminoacyl-transfer ribonucleic acid synthetases in Escherichia coli.

Authors:  F C Neidhardt; P L Bloch; S Pedersen; S Reeh
Journal:  J Bacteriol       Date:  1977-01       Impact factor: 3.490

5.  Two-dimensional gel electrophoresis of membrane proteins.

Authors:  G F Ames; K Nikaido
Journal:  Biochemistry       Date:  1976-02-10       Impact factor: 3.162

6.  Some improvements in two-dimensional gel electrophoresis of proteins. Protein mapping of eukaryotic tissue extracts.

Authors:  D L Wilson; M E Hall; G C Stone; R W Rubin
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

7.  Attachment of Mycoplasma pneumoniae to respiratory epithelium.

Authors:  D A Powell; P C Hu; M Wilson; A M Collier; J B Baseman
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

8.  Detection of serum proteins in the electrophoretic patterns of total proteins of mycoplasma cells.

Authors:  O E Yaguzhinskaya
Journal:  J Hyg (Lond)       Date:  1976-10

9.  Interaction of virulent Mycoplasma pneumoniae with hamster tracheal organ cultures.

Authors:  P C Hu; A M Collier; J B Baseman
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  Surface parasitism by Mycoplasma pneumoniae of respiratory epithelium.

Authors:  P C Hu; A M Collier; J B Baseman
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  30 in total

1.  Characterization of a major hemagglutinin protein from Mycoplasma gallisepticum.

Authors:  P F Markham; M D Glew; M R Brandon; I D Walker; K G Whithear
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Disulfide-linked protein associated with Mycoplasma pneumoniae cytadherence phase variation.

Authors:  M K Stevens; D C Krause
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

3.  Identification and complementation of a mutation associated with loss of Mycoplasma pneumoniae virulence-specific proteins B and C.

Authors:  Robert H Waldo; Jarrat L Jordan; Duncan C Krause
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

4.  Synthesis, stability, and function of cytadhesin P1 and accessory protein B/C complex of Mycoplasma pneumoniae.

Authors:  Robert H Waldo; Duncan C Krause
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

5.  Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium.

Authors:  Jarrat L Jordan; How-Yi Chang; Mitchell F Balish; Lynley S Holt; Stephanie R Bose; Benjamin M Hasselbring; Robert H Waldo; Thomas M Krunkosky; Duncan C Krause
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

6.  Parasitism of hamster trachea epithelial cells by Mycoplasma pneumoniae.

Authors:  Y Y Chen; D C Krause
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

7.  Expression of Mycoplasma pneumoniae antigens in Escherichia coli.

Authors:  L B Trevino; W G Haldenwang; J B Baseman
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

8.  Nucleotide sequence analysis reveals novel features of the phase-variable cytadherence accessory protein HMW3 of Mycoplasma pneumoniae.

Authors:  K F Ogle; K K Lee; D C Krause
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Distinct Mycoplasma pneumoniae Interactions with Sulfated and Sialylated Receptors.

Authors:  Caitlin R Williams; Li Chen; Edward S Sheppard; Pradeep Chopra; Jason Locklin; Geert-Jan Boons; Duncan C Krause
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

10.  Characterization of hemadsorption-negative mutants of Mycoplasma pneumoniae.

Authors:  E J Hansen; R M Wilson; W A Clyde; J B Baseman
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.